BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17303423)

  • 1. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis.
    Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN
    Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation.
    Wilton SD; Johnsen RD; Pedretti JR; Laing NG
    Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
    Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
    Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
    Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
    Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral mediated MyoD gene transfer into fibroblasts: myogenic disease diagnosis.
    Fujii I; Matsukura M; Ikezawa M; Suzuki S; Shimada T; Miike T
    Brain Dev; 2006 Aug; 28(7):420-5. PubMed ID: 16584859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
    Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
    Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cells.
    Chaouch S; Mouly V; Goyenvalle A; Vulin A; Mamchaoui K; Negroni E; Di Santo J; Butler-Browne G; Torrente Y; Garcia L; Furling D
    Hum Gene Ther; 2009 Jul; 20(7):784-90. PubMed ID: 19358679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.
    Hamed S; Sutherland-Smith A; Gorospe J; Kendrick-Jones J; Hoffman E
    Clin Genet; 2005 Jul; 68(1):69-79. PubMed ID: 15952989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of myogenic differentiation factors and skeletal muscle proteins in human amnion-derived cells via the forced expression of MYOD1.
    Akizawa Y; Kanno H; Kawamichi Y; Matsuda Y; Ohta H; Fujii H; Matsui H; Saito K
    Brain Dev; 2013 Apr; 35(4):349-55. PubMed ID: 22727434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
    Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
    Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.
    Sancho S; Mongini T; Tanji K; Tapscott SJ; Walker WF; Weintraub H; Miller AD; Miranda AF
    N Engl J Med; 1993 Sep; 329(13):915-20. PubMed ID: 8361505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
    Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
    Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of myoblast determining gene and connexin 43 gene on fibroblast differentiation and biological function in rats].
    Wang J; Fan H; Liu Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):857-61. PubMed ID: 17882885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre.
    Tuffery-Giraud S; Saquet C; Chambert S; Echenne B; Marie Cuisset J; Rivier F; Cossée M; Philippe C; Monnier N; Bieth E; Recan D; Antoinette Voelckel M; Perelman S; Lambert JC; Malcolm S; Claustres M
    Neuromuscul Disord; 2004 Oct; 14(10):650-8. PubMed ID: 15351422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins.
    Roest PA; van der Tuijn AC; Ginjaar HB; Hoeben RC; Hoger-Vorst FB; Bakker E; den Dunnen JT; van Ommen GJ
    Neuromuscul Disord; 1996 May; 6(3):195-202. PubMed ID: 8784808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients.
    Chelly J; Gilgenkrantz H; Hugnot JP; Hamard G; Lambert M; Récan D; Akli S; Cometto M; Kahn A; Kaplan JC
    J Clin Invest; 1991 Oct; 88(4):1161-6. PubMed ID: 1918370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR.
    Arning L; Jagiello P; Schara U; Vorgerd M; Dahmen N; Gencikova A; Mortier W; Epplen JT; Gencik M
    J Neurol; 2004 Jan; 251(1):72-8. PubMed ID: 14999492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.